We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Exposure to Sunlight Can Reduce Asthma

By HospiMedica staff writers
Posted on 13 Nov 2006
A new study has found that exposure to measured doses of ultraviolet (UV) light, such as in sunlight, can reduce asthma.

Researchers at the Telethon Institute for Child Health Research (Perth, Australia) studied the effect of UV light on the development of asthma-like symptoms in mice, such as inflamed airways and lungs. More...
Exposure to UV light for 15 to 30 minutes before allergen exposure was found to significantly reduce the development of asthma-like symptoms. The researchers found that UV exposure produces a cell type in a mouse that, when transferred into other mice, suppresses the immune reactions --apparently by causing an accumulation of regulatory T cells in the lymph nodes--halting symptoms and decreasing the bronchial hyper-reactivity typically found in asthmatic responses.

"This research clearly shows that controlled exposure to ultraviolet light markedly limits the development, incidence, and severity of asthma symptoms in mice,” said lead author, associate professor Prue Hart. "It appears that sunlight can suppress specific immune reactions, so we are now working to better understand that mechanism with the aim of generating new ways to prevent and treat this chronic disease.”

However, cautions professor Hart, "Given that overexposure to sunlight can cause skin cancer, it is important that we isolate and separate out the beneficial elements of ultraviolet light if we are to develop a safe and effective asthma therapy.”



Related Links:
Telethon Institute for Child Health Research

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ultrasound Needle Guidance System
SonoSite L25
ow Frequency Pulse Massager
ET10 L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.